Global Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Pipeline Review 2016 Featuring Incyte, Inflection Biosciences, Jasco Pharma & Novartis - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Serine/Threonine Protein Kinase Pim 2, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Serine/Threonine Protein Kinase Pim 2 and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Serine/Threonine Protein Kinase Pim 2 Overview
  3. Therapeutics Development
  4. Pipeline Products for Serine/Threonine Protein Kinase Pim 2 - Overview
  5. Pipeline Products for Serine/Threonine Protein Kinase Pim 2 - Comparative Analysis
  6. Serine/Threonine Protein Kinase Pim 2 - Therapeutics under Development by Companies
  7. Serine/Threonine Protein Kinase Pim 2 - Therapeutics under Investigation by Universities/Institutes
  8. Serine/Threonine Protein Kinase Pim 2 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Serine/Threonine Protein Kinase Pim 2 - Products under Development by Companies
  13. Serine/Threonine Protein Kinase Pim 2 - Products under Investigation by Universities/Institutes
  14. Serine/Threonine Protein Kinase Pim 2 - Companies Involved in Therapeutics Development
  • Incyte Corporation
  • Inflection Biosciences Limited
  • Jasco Pharmaceuticals, LLC.
  • Novartis AG

For more information about this drug pipelines visit http://www.researchandmarkets.com/research/rkkjj9/serinethreonine

Related Topics: Chemicals, Oncology Drugs, Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716